Cargando…
The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy
Coronavirus disease 2019 (COVID-19) is a severe respiratory disease caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that affects the lower and upper respiratory tract in humans. SARS-CoV-2 infection is associated with the induction of a cascade of uncontrolled i...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981974/ https://www.ncbi.nlm.nih.gov/pubmed/36875108 http://dx.doi.org/10.3389/fimmu.2023.1127358 |
_version_ | 1784900224688324608 |
---|---|
author | Hasankhani, Aliakbar Bahrami, Abolfazl Tavakoli-Far, Bahareh Iranshahi, Setare Ghaemi, Farnaz Akbarizadeh, Majid Reza Amin, Ali H. Abedi Kiasari, Bahman Mohammadzadeh Shabestari, Alireza |
author_facet | Hasankhani, Aliakbar Bahrami, Abolfazl Tavakoli-Far, Bahareh Iranshahi, Setare Ghaemi, Farnaz Akbarizadeh, Majid Reza Amin, Ali H. Abedi Kiasari, Bahman Mohammadzadeh Shabestari, Alireza |
author_sort | Hasankhani, Aliakbar |
collection | PubMed |
description | Coronavirus disease 2019 (COVID-19) is a severe respiratory disease caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that affects the lower and upper respiratory tract in humans. SARS-CoV-2 infection is associated with the induction of a cascade of uncontrolled inflammatory responses in the host, ultimately leading to hyperinflammation or cytokine storm. Indeed, cytokine storm is a hallmark of SARS-CoV-2 immunopathogenesis, directly related to the severity of the disease and mortality in COVID-19 patients. Considering the lack of any definitive treatment for COVID-19, targeting key inflammatory factors to regulate the inflammatory response in COVID-19 patients could be a fundamental step to developing effective therapeutic strategies against SARS-CoV-2 infection. Currently, in addition to well-defined metabolic actions, especially lipid metabolism and glucose utilization, there is growing evidence of a central role of the ligand-dependent nuclear receptors and peroxisome proliferator-activated receptors (PPARs) including PPARα, PPARβ/δ, and PPARγ in the control of inflammatory signals in various human inflammatory diseases. This makes them attractive targets for developing therapeutic approaches to control/suppress the hyperinflammatory response in patients with severe COVID-19. In this review, we (1) investigate the anti-inflammatory mechanisms mediated by PPARs and their ligands during SARS-CoV-2 infection, and (2) on the basis of the recent literature, highlight the importance of PPAR subtypes for the development of promising therapeutic approaches against the cytokine storm in severe COVID-19 patients. |
format | Online Article Text |
id | pubmed-9981974 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99819742023-03-04 The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy Hasankhani, Aliakbar Bahrami, Abolfazl Tavakoli-Far, Bahareh Iranshahi, Setare Ghaemi, Farnaz Akbarizadeh, Majid Reza Amin, Ali H. Abedi Kiasari, Bahman Mohammadzadeh Shabestari, Alireza Front Immunol Immunology Coronavirus disease 2019 (COVID-19) is a severe respiratory disease caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that affects the lower and upper respiratory tract in humans. SARS-CoV-2 infection is associated with the induction of a cascade of uncontrolled inflammatory responses in the host, ultimately leading to hyperinflammation or cytokine storm. Indeed, cytokine storm is a hallmark of SARS-CoV-2 immunopathogenesis, directly related to the severity of the disease and mortality in COVID-19 patients. Considering the lack of any definitive treatment for COVID-19, targeting key inflammatory factors to regulate the inflammatory response in COVID-19 patients could be a fundamental step to developing effective therapeutic strategies against SARS-CoV-2 infection. Currently, in addition to well-defined metabolic actions, especially lipid metabolism and glucose utilization, there is growing evidence of a central role of the ligand-dependent nuclear receptors and peroxisome proliferator-activated receptors (PPARs) including PPARα, PPARβ/δ, and PPARγ in the control of inflammatory signals in various human inflammatory diseases. This makes them attractive targets for developing therapeutic approaches to control/suppress the hyperinflammatory response in patients with severe COVID-19. In this review, we (1) investigate the anti-inflammatory mechanisms mediated by PPARs and their ligands during SARS-CoV-2 infection, and (2) on the basis of the recent literature, highlight the importance of PPAR subtypes for the development of promising therapeutic approaches against the cytokine storm in severe COVID-19 patients. Frontiers Media S.A. 2023-02-17 /pmc/articles/PMC9981974/ /pubmed/36875108 http://dx.doi.org/10.3389/fimmu.2023.1127358 Text en Copyright © 2023 Hasankhani, Bahrami, Tavakoli-Far, Iranshahi, Ghaemi, Akbarizadeh, Amin, Abedi Kiasari and Mohammadzadeh Shabestari https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Hasankhani, Aliakbar Bahrami, Abolfazl Tavakoli-Far, Bahareh Iranshahi, Setare Ghaemi, Farnaz Akbarizadeh, Majid Reza Amin, Ali H. Abedi Kiasari, Bahman Mohammadzadeh Shabestari, Alireza The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy |
title | The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy |
title_full | The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy |
title_fullStr | The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy |
title_full_unstemmed | The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy |
title_short | The role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by SARS-CoV-2 infection: A perspective for COVID-19 therapy |
title_sort | role of peroxisome proliferator-activated receptors in the modulation of hyperinflammation induced by sars-cov-2 infection: a perspective for covid-19 therapy |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9981974/ https://www.ncbi.nlm.nih.gov/pubmed/36875108 http://dx.doi.org/10.3389/fimmu.2023.1127358 |
work_keys_str_mv | AT hasankhanialiakbar theroleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT bahramiabolfazl theroleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT tavakolifarbahareh theroleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT iranshahisetare theroleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT ghaemifarnaz theroleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT akbarizadehmajidreza theroleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT aminalih theroleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT abedikiasaribahman theroleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT mohammadzadehshabestarialireza theroleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT hasankhanialiakbar roleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT bahramiabolfazl roleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT tavakolifarbahareh roleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT iranshahisetare roleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT ghaemifarnaz roleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT akbarizadehmajidreza roleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT aminalih roleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT abedikiasaribahman roleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy AT mohammadzadehshabestarialireza roleofperoxisomeproliferatoractivatedreceptorsinthemodulationofhyperinflammationinducedbysarscov2infectionaperspectiveforcovid19therapy |